Zobrazeno 1 - 10
of 189
pro vyhledávání: '"Christophe Verny"'
Autor:
Cinzia Bocca, Judith Kouassi-Nzoughet, Juan Manuel Chao de la Barca, Dominique Bonneau, Christophe Verny, Philippe Gohier, Christophe Orssaud, Pascal Reynier
Publikováno v:
Acta Neuropathologica Communications, Vol 12, Iss 1, Pp 1-3 (2024)
Externí odkaz:
https://doaj.org/article/4f745d54585a4808a18b008b47ac493d
Autor:
Jean-Francois Mangin, Denis Rivière, Edouard Duchesnay, Yann Cointepas, Véronique Gaura, Christophe Verny, Philippe Damier, Pierre Krystkowiak, Anne-Catherine Bachoud-Lévi, Philippe Hantraye, Philippe Remy, Gwenaëlle Douaud
Publikováno v:
NeuroImage: Clinical, Vol 26, Iss , Pp - (2020)
Huntington's disease (HD) is an inherited, autosomal dominant disorder that is characteristically thought of as a degenerative disorder. Despite cellular and molecular grounds suggesting HD could also impact normal development, there has been scarce
Externí odkaz:
https://doaj.org/article/aa8f8d6e4cc84a6aaa449c2ac2538ff0
Autor:
Philippe Allain, Martin Hamon, Virginie Saoût, Christophe Verny, Mickaël Dinomais, Jeremy Besnard
Publikováno v:
Frontiers in Neurology, Vol 10 (2020)
Background: In view of the recent literature, the negative impact of traumatic brain injury (TBI) on social cognition remains a debated issue. On one hand, a considerable number of studies reported significant impairments in emotion recognition, empa
Externí odkaz:
https://doaj.org/article/197c8c8506b544b088b3ac43104f2292
Autor:
Stéphanie Leruez, Christophe Verny, Dominique Bonneau, Vincent Procaccio, Guy Lenaers, Patrizia Amati-Bonneau, Pascal Reynier, Clarisse Scherer, Adriana Prundean, Christophe Orssaud, Xavier Zanlonghi, Marie-Bénédicte Rougier, Caroline Tilikete, Dan Miléa
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-9 (2018)
Abstract Backrground Evaluation of the efficacy of oral cyclosporine A as a prophylactic agent in preventing second-eye involvement in Leber’s hereditary optic neuropathy (LHON) in a prospective, open-label, non-randomized, multicenter pilot study.
Externí odkaz:
https://doaj.org/article/b5c070273686438d8909deeeb7d9a15a
Autor:
Anne-Catherine Bachoud-Lévi, Joaquim Ferreira, Renaud Massart, Katia Youssov, Anne Rosser, Monica Busse, David Craufurd, Ralf Reilmann, Giuseppe De Michele, Daniela Rae, Ferdinando Squitieri, Klaus Seppi, Charles Perrine, Clarisse Scherer-Gagou, Olivier Audrey, Christophe Verny, Jean-Marc Burgunder
Publikováno v:
Frontiers in Neurology, Vol 10 (2019)
The European Huntington's Disease Network (EHDN) commissioned an international task force to provide global evidence-based recommendations for everyday clinical practice for treatment of Huntington's disease (HD). The objectives of such guidelines ar
Externí odkaz:
https://doaj.org/article/d0adb6bc86654d5aac5758ac339767dd
Autor:
Juan Manuel Chao de la Barca, Delphine Prunier-Mirebeau, Patrizia Amati-Bonneau, Marc Ferré, Emmanuelle Sarzi, Céline Bris, Stéphanie Leruez, Arnaud Chevrollier, Valérie Desquiret-Dumas, Naïg Gueguen, Christophe Verny, Christian Hamel, Dan Miléa, Vincent Procaccio, Dominique Bonneau, Guy Lenaers, Pascal Reynier
Publikováno v:
Neurobiology of Disease, Vol 90, Iss , Pp 20-26 (2016)
Mutations in the Optic Atrophy 1 gene (OPA1) were first identified in 2000 as the main cause of Dominant Optic Atrophy, a disease specifically affecting the retinal ganglion cells and the optic nerve. Since then, an increasing number of symptoms invo
Externí odkaz:
https://doaj.org/article/7a66761b919e48789ee9bffc3c58a9b2
Autor:
Clémence Simonin, Cécile Duru, Julia Salleron, Pascale Hincker, Perrine Charles, Arnaud Delval, Katia Youssov, Sylvie Burnouf, Jean-Philippe Azulay, Christophe Verny, Clarisse Scherer, Christine Tranchant, Cyril Goizet, Sabrina Debruxelles, Luc Defebvre, Bernard Sablonnière, Monique Romon-Rousseaux, Luc Buée, Alain Destée, Olivier Godefroy, Alexandra Dürr, Bernhard Landwehrmeyer, Anne-Catherine Bachoud-Levi, Florence Richard, David Blum, Pierre Krystkowiak
Publikováno v:
Neurobiology of Disease, Vol 58, Iss , Pp 179-182 (2013)
Habitual consumption of caffeine, a non-selective adenosine receptor (AR) antagonist, has been suggested to be beneficial in Parkinson's and Alzheimer's diseases. Experimental evidence support that ARs play a role in Huntington's disease (HD) raising
Externí odkaz:
https://doaj.org/article/c66d747e16594f4389dca9b322499c97
Autor:
Ruth de Diego-Balaguer, Catherine Schramm, Isabelle Rebeix, Emmanuel Dupoux, Alexandra Durr, Alexis Brice, Perrine Charles, Laurent Cleret de Langavant, Katia Youssov, Christophe Verny, Vincent Damotte, Jean-Philippe Azulay, Cyril Goizet, Clémence Simonin, Christine Tranchant, Patrick Maison, Amandine Rialland, David Schmitz, Charlotte Jacquemot, Bertrand Fontaine, Anne-Catherine Bachoud-Lévi, French Speaking Huntington Group
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0161106 (2016)
Little is known about the genetic factors modulating the progression of Huntington's disease (HD). Dopamine levels are affected in HD and modulate executive functions, the main cognitive disorder of HD. We investigated whether the Val158Met polymorph
Externí odkaz:
https://doaj.org/article/ce1eff47281e424abe8ed33bbb731069
Autor:
Linda Salem, Nadine Saleh, Gaelle Désaméricq, Katia Youssov, Guillaume Dolbeau, Laurent Cleret, Marie-Laure Bourhis, Jean-Philippe Azulay, Pierre Krystkowiak, Christophe Verny, Françoise Morin, Stéphane Moutereau, French Huntington Study Group, Anne-Catherine Bachoud-Lévi, Patrick Maison
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0162890 (2016)
BACKGROUND:Huntington's disease (HD) is one of several neurodegenerative disorders that have been associated with metabolic alterations. Changes in Insulin Growth Factor 1 (IGF-1) and/or insulin input to the brain may underlie or contribute to the pr
Externí odkaz:
https://doaj.org/article/d458497426e74f66a74221c9d2cbfd54
Autor:
Laurent Cleret de Langavant, Sophie Sudraud, Christophe Verny, Pierre Krystkowiak, Clémence Simonin, Philippe Damier, Jean-François Demonet, Frédéric Supiot, Amandine Rialland, David Schmitz, Patrick Maison, Katia Youssov, Anne-Catherine Bachoud-Lévi
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0128209 (2015)
There is an urgent need to assess and improve the consent process in clinical trials of innovative therapies for neurodegenerative disorders.We performed a longitudinal study of the consent of Huntington's disease patients during the Multicenter Feta
Externí odkaz:
https://doaj.org/article/fb66a675a70a413f8333d73ceb1f30a9